Fresenius Medical (Germany) Statistic Functions Beta

FMEA Stock  EUR 20.20  0.70  3.59%   
This statistic functions tool runs Beta function and companion studies for Fresenius Medical. This view tracks statistical functions describing dispersion and variability to support structured performance interpretation without implying advice. Enter Time Period to generate the indicator output.

This analysis covers thirty-seven data points across the selected time horizon. The Beta measures systematic risk based on how returns on Fresenius Medical Care correlated with the market. If Beta is less than 0 Fresenius Medical generally moves in the opposite direction as compared to the market. If Fresenius Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Fresenius Medical Care is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Fresenius Medical is generally in the same direction as the market. If Beta > 1 Fresenius Medical moves generally in the same direction as, but more than the movement of the benchmark.

Fresenius Medical Technical Analysis Modules

Technical analysis of Fresenius Medical uses historical price and volume data to identify patterns that may signal where the Fresenius trend is heading. Consider the broader market regime when interpreting Fresenius technical signals, as sector-wide moves can dominate individual patterns.

Methodology, Assumptions & Data Sources

The Statistic Functions time series for Fresenius Medical serves as a benchmark for evaluating directional shifts in this metric. Comparing this metric against sector peers can reveal relative positioning.

This section for Fresenius Medical Care is built from periodic company reporting and market reference feeds, with harmonization applied to align reporting definitions. Values may update on different source schedules.

This content is curated and reviewed by:

Ellen Johnson - Member of Macroaxis Editorial Board
Last reviewed on March 15th, 2026